Olga Goślińska

Olga Goślińska

Auto-generated profile, based on publicly available information

Olga Goślińska

Department of Medical Microbiology, University of Medical Sciences in Poznań, Wieniawskiego 3, Str., 61–712, Poznań, Poland

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Fitoterapia
Verified
Journal Article
Closed access
BTBarbara Thiem
Barbara Thiem
OGO. Goślińska
O. Goślińska

1 July 2005 in Fitoterapia
Verified
Journal Article
Closed access
EWEwa Witkowska-Banaszczak
Ewa Witkowska-Banaszczak
WBWiesława Bylka
Wiesława Bylka
IMIrena Matławska
Irena Matławska
OGOlga Goślińska
Olga Goślińska
ZMZygmunt Muszyński
Zygmunt Muszyński

1 July 2004 in Letters in Applied Microbiology
Verified
Journal Article
Closed access
PDF file
WBW. Bylka
W. Bylka
MSM. Szaufer-Hajdrych
M. Szaufer-Hajdrych
IMI. Matlawska
I. Matlawska
OGO. Goslinska
O. Goslinska

31 January 2016 in Fibres & Textiles in Eastern Europe
Verified
Journal Article
Closed access
Malgorzata ZimniewskaMalgorzata Zimniewska
Malgorzata Zimniewska
OGOlga Goślińska-Kuźniarek
Olga Goślińska-Kuźniarek

11 February 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAndrzej Szkaradkiewicz
Andrzej Szkaradkiewicz
Tomasz M. KarpinskiTomasz M. Karpinski
Tomasz M. Karpinski
KLKrzysztof Linke
Krzysztof Linke
PMPrzemysław Majewski
Przemysław Majewski
DRDorota Rożkiewicz
Dorota Rożkiewicz
OGOlga Goślińska-Kuźniarek
Olga Goślińska-Kuźniarek
In order to better understand pathogenicity of Helicobacter pylori, particularly in the context of its carcinogenic activity, we analysed expression of virulence genes: cagA, virB/D complex (virB4, virB7, virB8, virB9, virB10, virB11, virD4) and vacA in strains of the pathogen originating from persons with gastric diseases. The studies were conducted on 42 strains of H. pylori isolated from patients with histological diagnosis of non-atrophic gastritis—NAG (group 1, including subgroup 1 containing cagA+ isolates and subgroup 2 containing cagA- strains), multifocal atrophic gastritis—MAG (group 2) and gastric adenocarcinoma—GC (group 3). Expression of H. pylori genes was studied using microarray technology. In group 1, in all strains of H. pylori cagA+ (subgroup 1) high expression of the gene as well as of virB/D was disclosed, accompanied by moderate expression of vacA. In strains of subgroup 2 a moderate expression of vacA was detected. All strains in groups 2 and 3 carried cagA gene but they differed in its expression: a high expression was detected in isolates of group 2 and its hyperexpression in strains of group 3 (hypervirulent strains). In both groups high expression of virB/D and vacA was disclosed. Our results indicate that chronic active gastritis may be induced by both cagA+ strains of H. pylori, manifesting high expression of virB/D complex but moderate activity of vacA, and cagA- strains with moderate expression of vacA gene. On the other hand, in progression of gastric pathology and carcinogenesis linked to H. pylori a significant role was played by hypervirulent strains, manifesting a very high expression of cagA and high activity of virB/D and vacA genes.